A single dose of psilocybin induces changes in perception and mystical-type experience and significantly lowered levels of anxiety and depression.

‘An active ingredient in magic mushrooms called psilocybin has been found to decrease negative mood in patients with life-threatening cancer.’

In this new study, Roland Griffiths and colleagues from the Johns Hopkins University School of Medicine investigated the effects of psilocybin on symptoms of anxiety and depression in individuals diagnosed with life-threatening cancer. 




Five weeks after receiving a dose of psilocybin sufficiently high to induce changes in perception and mystical-type experiences, patients reported significantly lower levels of anxiety and depression compared with patients that received a low dose of the drug. The positive effects on mood persisted in the patients at 6 month follow-up.
The authors suggest that a single dose of psilocybin may be sufficient to produce enduring decreases in negative mood in patients with a life-threatening cancer.
The study was presented at the annual meeting of the American College of Neuropsychopharmacology.
Source-Eurekalert